Isoflavones linked to elevated risk of advanced prostate cancer in new study

494a57f9-eb9f-4200-8637-15b026652ce1articleimage.jpg

09 Nov 2017 --- An International Journal of Cancer study has linked the dietary intake of isoflavones to an elevated risk of advanced prostate cancer. Isoflavones are a type of phytoestrogen, a family of estrogen-like compounds found in plants and are found in soybeans, kudzu root and American groundnuts. The study notes that no statistically significant associations were observed between the intake of isoflavones and non-advanced prostate cancer in the study.

Much of the previous findings related to the compounds have been positive. Soy isoflavones have previously been linked to easing the symptoms of polycystic ovary syndrome with improvements being seen in areas including levels of insulin resistance. Soy isoflavones have also been found to offer protection against menopausal symptoms and coronary heart disease.

During a median follow up of 11.5 years for the International Journal of Cancer study, 2,598 cases of prostate cancer (including 287 advanced cases) were identified among 27,004 men in the intervention arm of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Dietary intake was assessed with a food frequency questionnaire.

“Prostate cancer is a major cancer in Western countries, and its incidence rate has been remarkably increasing in Asian countries during the last several decades,” says senior author Dr. Jianjun Zhang, of the Indiana University Fairbanks School of Public Health. “Our study offers novel evidence that dietary intake of isoflavones has different effects on advanced and non-advanced prostate cancer.”

“This observation is important for understanding the etiology and prevention of prostate cancer but needs to be confirmed in more epidemiologic studies among populations with diverse dietary habits,” Zhang concludes.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Glanbia targets modern lifestyle demands with new performance nutrition ingredients 

17 May 2018 --- Glanbia Nutritionals has launched two new performance nutrition ingredients for formulation in functional beverages in Europe, the Middle East and Africa. Ignitor and WheyXR were developed to enhance amino acid release, allowing manufacturers to maximize the health benefits of protein supplementation. Both ingredients target the ever-expanding market for sports nutrition options and were included in its range of prototypes at this year’s Vitafoods Europe 2018, which showcased Glanbia’s portfolio and applications expertise.

Nutrition & Health News

Paleo candy: Partnership accelerates health conscious snacking space

16 May 2018 --- Hu products, makers of organic, paleo and vegan chocolate, have received new investment and partnership from Sonoma Brands, a unique food and beverage products incubator. With its beginnings in the paleo-inspired New York-based restaurant, Hu Kitchen, Hu Chocolate says that it is now ready to “accelerate the expansion of its global reach and propel its growth in the health-conscious snacking space.”

Nutrition & Health News

“Key milestone”: Chr. Hansen trial finds probiotic potential for painkiller gut damage defense

16 May 2018 --- A Chr. Hansen clinical trial has demonstrated the effectiveness of probiotic strains in protecting against potential gut damage caused by the regular use of household painkillers. Chr. Hansen state that they will now focus on fully exploiting the strains full potential, deepening understanding of the underlying mechanisms and gathering sufficient data to publish in a scientific journal. The findings add to a growing research area using probiotics for health.

Nutrition & Health News

Vitamin D may play a role in children's non-alcoholic liver disease, study finds

15 May 2018 --- Children with non-alcoholic fatty liver disease (NAFLD) have particularly low vitamin D status and suffer from vitamin D insufficiency throughout the year, new research has found. The research, published in Pediatric Obesity, charted vitamin D levels and variations in genes that determine vitamin D status, in British children diagnosed with the liver disease. The findings open up potential future possibilities for treatment using vitamin D.

Nutrition & Health News

Takeda Pharmaceutical takes over Shire in US$62bn deal

08 May 2018 --- Takeda Pharmaceutical has reached a deal to buy Shire Plc. for US$62 billion in a move hoped to rapidly boost Takeda’s global standing as a biopharmaceutical leader. It is predicted to bring together Takeda and Shire’s complementary positions in gastroenterology (GI), neuroscience and more. Also, it may advance Shire’s portfolio with Takeda’s strong presence in emerging markets and Japan.

More Articles
URL : http://www.nutritioninsight.com:80/news/isoflavones-linked-to-elevated-risk-of-advanced-prostate-cancer-in-new-study.html